Actualités Amgen Inc - 0R0T | Actions London Stock Exchange

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition PR...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 06 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Drugmakers agree to US government price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 29 September 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

Adage Capital Partners LP Form 8.3/Form 38.5(a) - Horizon Therapeutics PLC

Adage Capital Partners LP 28 September 2023 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 28 September 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

Adage Capital Partners LP Form 8.3 - Horizon Therapeutics PLC

Adage Capital Partners LP 27 September 2023 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amgen Inc (0R0T)

Outils de qualité professionnelle, pour des investisseurs individuels.

0R0T Actualités

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Drugmakers agree to US government price talks amid pushback

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3/Form 38.5(a) - Horizon Therapeutics PLC

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3 - Horizon Therapeutics PLC

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amgen Inc (0R0T) Actualités

Amgen Inc (0R0T)

Outils de qualité professionnelle, pour des investisseurs individuels.

0R0T Actualités

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Drugmakers agree to US government price talks amid pushback

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3/Form 38.5(a) - Horizon Therapeutics PLC

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3 - Horizon Therapeutics PLC

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités